Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifampin effect on TAK-906 PK in healthy adults
NCT04121078Phase 1Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Oct 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of trazpiroben in gastroparesis (2 arms), sponsored by Millennium Pharmaceuticals. Primary endpoints: Maximum Observed Plasma Concentration at Day 1, Area Under the Plasma Concentration-time Curve From Time 0 to Infinity at Day 1 and 1 more. Started Oct 2019; status: completed.
02
Drugs
trazpiroben
03
Conditions
gastroparesis
Beyond the preview
Go deeper on NCT04121078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04121078.